Aaron Fisher

Director, Life Sciences Investments at ARCHIMED

Speaker

Aaron is a career institutional investor with 14+ years of experience in investment banking, growth and private equity investing. He has spent the majority of his investment career focused in healthcare investing, and the last 6 years focused in life sciences, pharma services, and diagnostics. Today, Aaron co-leads ARCHIMED’s life sciences global investment team. Aaron has served on the board of a number of life science companies including SeqCenter, Empire Genomics (sold to Biocare), Sanguine Biosciences, Flagship Biosciences and Horizon Infusions (sold to Rubicon Founders). Aaron graduated from the University of Virginia and has an MBA from the Wharton School at the University of Pennsylvania.